IGC Pharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for IGC Pharma, Inc. (IGC) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2019
Period EndingDec 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2019
Current Assets
Cash and Cash Equivalents0.411.203.2010.4614.6325.61
Short-Term Investments0.000.000.150.000.080.00
Cash & Short-Term Investments0.411.203.3510.4614.6325.61
Accounts Receivable0.080.040.130.130.180.08
Inventory1.361.542.653.555.480.25
Other Current Assets1.050.720.260.340.200.02
Total Current Assets2.903.716.4715.1123.5226.72
Non-Current Assets
Property, Plant & Equipment (Net)3.323.898.549.8711.335.89
Long-Term Investments0.680.000.000.000.010.00
Intangible Assets1.851.621.170.920.410.00
Other Non-Current Assets0.000.691.000.940.600.00
Total Non-Current Assets5.856.2010.7111.7212.357.74
Total Assets8.759.9017.1826.8335.8734.47
Current Liabilities
Accounts Payable0.882.340.530.982.060.43
Short-Term Debt0.090.000.000.000.300.00
Current Portion of Long-Term Debt0.000.000.000.000.300.00
Accrued Liabilities0.281.020.881.211.180.00
Other Current Liabilities1.280.820.360.180.850.04
Total Current Liabilities2.262.341.902.442.370.88
Non-Current Liabilities
Long-Term Debt0.140.220.140.140.680.00
Other Non-Current Liabilities0.020.020.000.020.020.00
Total Non-Current Liabilities0.160.240.370.500.700.02
Total Liabilities2.422.582.272.943.060.89
Stockholders' Equity
Common Stock130.57124.41118.97116.02109.720.00
Retained Earnings-120.74-117.09-100.67-89.16-76.92-58.05
Accumulated Other Comprehensive Income-3.50-3.42-3.39-2.97-2.77-2.42
Shares Outstanding80.8866.6953.0851.050.000.00
Total Stockholders' Equity6.337.3214.9123.8932.8033.57
Total Liabilities & Equity8.759.9017.1826.8335.8734.47